Table 3.
Pathological features after propensity score matching.
| Intubated | Non-intubated | p-value | |
|---|---|---|---|
| (n = 158) | (n = 79) | ||
| Differentiation | .73 | ||
| Well | 29 (18.4) | 16 (20.3) | |
| Moderate poor | 129 (81.6) | 63 (79.7) | |
| VPI | 50 (31.6) | 20 (25.3) | .31 |
| LVI | 26 (16.5) | 19 (24.1) | .16 |
| Resection margin involvement | 12 (7.6) | 11 (13.9) | .12 |
| Pathological T stage | .98 | ||
| I | 98 (62.0) | 50 (63.3) | |
| II | 49 (31.0) | 24 (30.4) | |
| III | 11 (7.0) | 5 (6.3) | |
| Pathological N stage | .68 | ||
| I | 149 (94.3) | 76 (96.2) | |
| II | 5 (3.2) | 1 (1.3) | |
| III | 4 (2.5) | 2 (2.5) | |
| Histology | .17 | ||
| Adenocarcinoma | 117 (74.1) | 66 (83.5) | |
| SqCC | 18 (11.4) | 9 (11.4) | |
| Adenosquamous | 17 (10.8) | 3 (3.8) | |
| Pleomorphic | 5 (3.2) | 0 (0) | |
| Carcinoid | 1 (0.6) | 1 (1.3) |
Data are presented as mean ± SD or number (%).
LVI, lymphovascular invasion; VPI, visceral pleural invasion; SqCC, squamous cell carcinoma.